Login to Your Account



Financings Roundup


Wednesday, July 27, 2011
Novira Therapeutics Inc., of Radnor, Pa., completed a second round of seed funding to bring its early financing total to about $2.5 million, with another $1 million obtained in nondilutive grants. The latest financing was led by Philadelphia angel groups Delaware Crossing Investor Group, the Mid-Atlanta Angel Group Fund II and Robin Hood Ventures.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription